about us

Accelovance is an award winning, clinical development Contract Research Organization (CRO) focused on vaccine, oncology, and general medicine Phase I-IV programs. Providing global full CRO services to pharmaceutical companies, biotechs, CROs, and academic institutions; Accelovance supports client needs by leveraging operational knowledge and patient recruitment strategies that result in successful clinical trials.

Accelovance owns and operates a Clinical Call Center that assists in recruitment, retention, and surveillance. This knowledge, applied externally to sites and coupled with the therapeutic talent and experience of our team members, creates predictable, controlled enrollment and retention of quality patients ensuring study success.

Unique in comparison to most CROs, Accelovance provides complete clinical trial understanding and expertise by leveraging knowledge gained from our investigative site network subsidiary, Optimal Research, a US site management organization. The network includes wholly-owned research centers and a network of pediatric and oncology-focused clinical sites, enabling Optimal to conduct pediatric and oncology research as well as healthy volunteer and general population studies. These sites are structured for productivity – combining proven patient recruitment efforts with properly resourced staff and engaged/experienced Principal Investigators.

Accelovance has been named Vaccine Industry Excellence’s (ViE) Best CRO in 2009, 2010, and 2011; and received a “Highly Recommended” distinction in 2013. This external validation of Accelovance’s vaccine research experience and success is a result of our ability to guarantee budgets, control timelines, and accelerate patient enrollment – delivering business solutions that address our clients’ clinical needs.

Established in 2005 with a corporate mission to improve the quality and predictability in clinical research, Accelovance has made significant strides in the industry by combining strong business and operational perspective with clinical and medical expertise.

Mission and Vision

Accelovance's mission is to unite our world-class expertise to advance innovative treatments through clinical development. We accomplish this by

  • being an employer and vendor of choice
  • engaging a culture of extraordinary client service
  • providing innovative solutions to our clients most difficult challenges
  • recruiting and retaining the most talented work force available
  • providing a challenging working environment
  • providing continuous improvement and continuous learning for our employees

Accelovance's vision is to collaborate with partners to strategically advance medical research and development to improve the health and wellness of mankind.

How can this level of performance from a committed CRO partner impact the journey of your next study?

About Accelovance

Accelovance is an award-winning, niche CRO focused primarily in oncology, vaccines, and general medicine. Accelovance operates three core service divisions:


Our executive management team combines entrepreneurial business talents, clinical and medical expertise, and biotech industry experience.